Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Tables)

v3.19.3
Note 8 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Tables)
9 Months Ended
Sep. 30, 2019
Tables/Schedules  
Schedule of Notes receivable from G Farma

 

 

 

September 30,

2019

 

December 31,

2018

Real estate note

$

 111,009

$

 111,843

Working capital note

 

934,042

 

909,507

Impairment recorded

 

(1,045,051)

 

-

Note receivable discount

 

-

 

(7,591)

Accrued interest

 

-

 

3,067

 

 

-

 

1,016,826

Less current portion

 

-

 

(45,173)

Long term portion of notes receivable

$

 -

$

 971,653